Vaughn V. Smider

The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.

Enkefalos Biosciences, Inc. provides biotechnology services. The CEO of the American company is Duncan McGregor.

Minotaur Therapeutics is a private biotechnology company that specializes in developing unique biotherapeutics for oncology and immunology. The company is based in San Diego, CA. The company uses the novel ultralong cdr h3 scaffold of bovine antibodies to achieve unique targeting properties. Minotaur has licensing and partnership arrangements with the Applied Biomedical Science Institute and OmniAb on this emerging therapeutic class and its underlying technologies. The CEO of the company is Vaughn V. Smider.

Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA.

Fabrus, Inc. engages in discovering, developing and engineering therapeutic antibodies. It utilizes multiple proprietary product engines that define a new antibody discovery paradigm. The company is headquartered in San Diego, CA.